Imidazopiperazine inhibitors of transcription activating proteins
US-12559497-B2 · Feb 24, 2026 · US
This page is not indexed by search engines while we improve data quality.
Le Kang patents
Le Kang is listed as an inventor on 48 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Le Kang |
| Total patents | 48 |
| First publication | Jul 30, 2015 |
| Latest publication | Feb 24, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Imidazopiperazine inhibitors of transcription activating proteins
US-12540139-B2 · Feb 3, 2026 · US
Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1h-1,2,3-triazole-4-carboxamide
US-2025250253-A1 · Aug 7, 2025 · US
Heterocycles as modulators of nsd activity
US-2025243209-A1 · Jul 31, 2025 · US
Imidazopiperazine inhibitors of transcription activating proteins
US-2025127792-A1 · Apr 24, 2025 · US
Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide
US-12252480-B2 · Mar 18, 2025 · US
Inhibitors of mutant idh1 and idh2
US-2025049809-A1 · Feb 13, 2025 · US
Imidazopiperazine inhibitors of transcription activating proteins
US-12186324-B2 · Jan 7, 2025 · US
Gls1 inhibitors for treating disease
US-2024360121-A1 · Oct 31, 2024 · US
GLS1 inhibitors for treating disease
US-11958849-B2 · Apr 16, 2024 · US
Recent patents
Latest publications not already listed above.
Imidazopiperazine inhibitors of transcription activating proteins
US-2023312588-A1 · Oct 5, 2023 · US
Imidazopiperazine inhibitors of transcription activating proteins
US-2023295173-A1 · Sep 21, 2023 · US
Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1h-1,2,3-triazole-4-carboxamide
US-2023250081-A1 · Aug 10, 2023 · US
Gls1 inhibitors for treating disease
US-2023124815-A1 · Apr 20, 2023 · US
Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1H-1,2,3-triazole-4-carboxamide
US-11603365-B2 · Mar 14, 2023 · US
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease
US-11560366-B2 · Jan 24, 2023 · US
Imidazopiperazine inhibitors of transcription activating proteins
US-2023008047-A1 · Jan 12, 2023 · US
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (dlk) kinase for the treatment of disease
US-2022267311-A1 · Aug 25, 2022 · US
GLS1 inhibitors for treating disease
US-11370786-B2 · Jun 28, 2022 · US
Imidazopiperazine inhibitors of transcription activating proteins
US-11058688-B2 · Jul 13, 2021 · US
Salt forms and polymorphs of (r)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido) pyridazin-3-yl)-2-fluorobutyl)-n-methyl-1h-1,2,3-triazole-4-carboxamide
US-2021206745-A1 · Jul 8, 2021 · US
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (dlk) kinase for the treatment of disease
US-2021115010-A1 · Apr 22, 2021 · US
Imidazopiperazinone inhibitors of transcription activating proteins
US-10899769-B2 · Jan 26, 2021 · US
Salt forms and polymorphs of (R)-1-(4-(6-(2-(4-(3,3-difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide
US-10899740-B2 · Jan 26, 2021 · US
Gls1 inhibitors for treating disease
US-2020407353-A1 · Dec 31, 2020 · US
GLS1 inhibitors for treating disease
US-10766892-B2 · Sep 8, 2020 · US
Salts of bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (dlk) kinase for the treatment of disease
US-2019382396-A1 · Dec 19, 2019 · US
Imidazopiperazinone inhibitors of transcription activating proteins
US-2019308978-A1 · Oct 10, 2019 · US
Imidazopiperazine inhibitors of transcription activating proteins
US-2019298729-A1 · Oct 3, 2019 · US
Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease
US-10428057-B2 · Oct 1, 2019 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Texas | 43 |
| Hoffmann La Roche | 5 |
| Hoffmann La Roche | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 39 |
| A61K45/06 | 33 |
| C07D401/14 | 30 |
| A61P25/00 | 28 |
| A61K31/501 | 20 |